Investors' interest represents the rising demand for digital-therapeutic instruments and products across the healthcare ecosystem, which has been sustained by two key trends.
Fremont, CA: Investments in digital-therapeutic companies in the U.S. have increased in recent years by an average of 40 percent a year to hit over $1 billion in 2018. Investors' interest represents the rising demand for digital-therapeutic instruments and products across the healthcare ecosystem, which has been sustained by two key trends.
These trends advance the usefulness of digital therapeutics and focus from all stakeholders in the healthcare system. Patients that are familiar with digital consumer apps want healthcare products that are relevant and informative. While doctors, many of whom are digital natives, are willing to digitally meet their patients and businesses. In addition, providers and payers want digital resources that help them serve more effectively and reduce the cost to superior numbers of patients. Pharmaceutical and medical device companies aim to create digital technologies that extend and replace new therapies. In addition, the U.S. Therefore, the regulatory system is established by the Food and Drug Administration (FDA) to boost digital innovation in healthcare.
A look at some of the start-ups with products coming to the market provides a sense of the various methods employed by these emerging digital therapies to healthcare problems. These products include video games to treat behavioral and mental and health issues, a digital rehabilitation network incorporating neurological music therapy, artificial intelligence (AI), and sensors to help restore motor skills for patients who have experienced a stroke or other neurological condition. It also provides an app for smartphones that can perform electrocardiograms at any time and anywhere.